Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 24, 2024 • 9:00 AM ET

Date/Time Source News Release
11/21/2024 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
11/12/2024 08:00 AM EST GlobeNewswire Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/07/2024 07:00 AM EST GlobeNewswire Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
11/04/2024 07:00 AM EST GlobeNewswire Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
10/29/2024 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
10/16/2024 08:00 AM EDT GlobeNewswire Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
09/26/2024 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit
05/09/2024 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
05/07/2024 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
05/01/2024 08:00 AM EDT GlobeNewswire Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
Page

Additional News

As of November 24, 2024 • 9:00 AM ET

Date/Time Source News Release
Page